Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Detels

Showing results (241-250 of 284) with videos related to

Pageof 29
Sort By:
Plos One|November 27, 2013
Factors affecting the prevalence of strongly and weakly carcinogenic and lower-risk human papillomaviruses in anal specimens in a cohort of men who have sex with men (MSM)Dorothy J Wiley, Xiuhong Li, Hilary Hsu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2008
Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survivalSher L Hendrickson, Lisa P Jacobson, George W Nelson, et al.
AIDS (London, England)|December 15, 2010
Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control studyMarcel E Curlin, Farah Cassis-Ghavami, Amalia S Magaret, et al.
Atherosclerosis|April 5, 2012
Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort studyRulin C Hechter, Matthew Budoff, Howard N Hodis, et al.
AIDS Research and Treatment|April 15, 2011
Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's LymphomaDaniel P Widney, Dorina Gui, Laura M Popoviciu, et al.
American Journal of Epidemiology|September 26, 2003
Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural modelsStephen R Cole, Miguel A Hernán, James M Robins, et al.
AIDS and Behavior|May 4, 2024
Longitudinal Analysis of Overlapping Psychosocial Factors Predicting Incident Hospitalization Among Mixed HIV Serostatus Men who have Sex with Men in the Multicenter AIDS Cohort StudyYuhang Qian, Roger Detels, Warren Scott Comulada, et al.
Journal of Virology|November 27, 2004
Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infectionMaureen P Martin, Michael M Lederman, Holli B Hutcheson, et al.
Nature Genetics|July 23, 2002
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDSMaureen P Martin, Xiaojiang Gao, Jeong-Hee Lee, et al.
Mbio|November 30, 2017
Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag EpitopesYushen Du, Tian-Hao Zhang, Lei Dai, et al.
Pageof 29

Showing results (241-250 of 284) with videos related to

Sort By:
Pageof 29
Plos One|November 27, 2013
Factors affecting the prevalence of strongly and weakly carcinogenic and lower-risk human papillomaviruses in anal specimens in a cohort of men who have sex with men (MSM)Dorothy J Wiley, Xiuhong Li, Hilary Hsu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2008
Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survivalSher L Hendrickson, Lisa P Jacobson, George W Nelson, et al.
AIDS (London, England)|December 15, 2010
Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control studyMarcel E Curlin, Farah Cassis-Ghavami, Amalia S Magaret, et al.
Atherosclerosis|April 5, 2012
Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort studyRulin C Hechter, Matthew Budoff, Howard N Hodis, et al.
AIDS Research and Treatment|April 15, 2011
Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's LymphomaDaniel P Widney, Dorina Gui, Laura M Popoviciu, et al.
American Journal of Epidemiology|September 26, 2003
Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural modelsStephen R Cole, Miguel A Hernán, James M Robins, et al.
AIDS and Behavior|May 4, 2024
Longitudinal Analysis of Overlapping Psychosocial Factors Predicting Incident Hospitalization Among Mixed HIV Serostatus Men who have Sex with Men in the Multicenter AIDS Cohort StudyYuhang Qian, Roger Detels, Warren Scott Comulada, et al.
Journal of Virology|November 27, 2004
Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infectionMaureen P Martin, Michael M Lederman, Holli B Hutcheson, et al.
Nature Genetics|July 23, 2002
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDSMaureen P Martin, Xiaojiang Gao, Jeong-Hee Lee, et al.
Mbio|November 30, 2017
Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag EpitopesYushen Du, Tian-Hao Zhang, Lei Dai, et al.
Pageof 29